Fig. 7

AKBA mediates BST2 to improve HPMECs dysfunction. (A, B) Fluorescence intensity and cellular localization of BST2, (630×magnification). (C) Fluorescence intensity and cellular localization of U-STAT1, (630× magnification). (D) Cell viability was evaluated by CCK8 assay. (E) The permeability of HPMECs was evaluated by the vascular permeability marker Evans Blue. (F, G) The apoptosis level of HPMECs was evaluated by flow cytometry. n = 3. *p < 0.05, **p < 0.01 and ***p < 0.001.